Your session is about to expire
← Back to Search
Device
Nano-Pulse Stimulation (NPS) Treated Lesion for Seborrheic Keratosis
N/A
Waitlist Available
Research Sponsored by Pulse Biosciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-last treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new treatment called Nano-Pulse Stimulation (NPS) to remove skin lesions in healthy adults. The treatment uses short electrical pulses to clear the lesions without harming nearby skin. The study aims to find the best settings for this treatment and check for any side effects.
Eligible Conditions
- Seborrheic Keratosis
- Skin Lesions
- Benign Skin Tumor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days post-last treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-last treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clearance Rate of SK Lesions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nano-Pulse Stimulation (NPS) Treated LesionExperimental Treatment1 Intervention
Nano-Pulse Stimulation of targeted lesion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nano-Pulse Stimulation (NPS)
2017
N/A
~60
Find a Location
Who is running the clinical trial?
Pulse Biosciences, Inc.Lead Sponsor
10 Previous Clinical Trials
677 Total Patients Enrolled
Richard A Nuccitelli, PhDStudy ChairPulse Biosciences, Inc.
2 Previous Clinical Trials
183 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger